132 related articles for article (PubMed ID: 1842169)
21. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM
J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
[TBL] [Abstract][Full Text] [Related]
22. From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.
Sanger GJ; King FD
Drug Des Deliv; 1988 Dec; 3(4):273-95. PubMed ID: 3076395
[TBL] [Abstract][Full Text] [Related]
23. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
Hainsworth JD
Semin Surg Oncol; 1993; 9(3):279-84. PubMed ID: 8516617
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.
Tyers MB; Freeman AJ
Oncology; 1992; 49(4):263-8. PubMed ID: 1387926
[TBL] [Abstract][Full Text] [Related]
25. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
[TBL] [Abstract][Full Text] [Related]
26. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
27. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Aapro M; Blower P
Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
Cheng FH; Andrews PL; Moreaux B; Ngan MP; Rudd JA; Sam TS; Wai MK; Wan C
Eur J Pharmacol; 2005 Jan; 508(1-3):231-8. PubMed ID: 15680276
[TBL] [Abstract][Full Text] [Related]
29. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients.
Tremblay PB; Kaiser R; Sezer O; Rosler N; Schelenz C; Possinger K; Roots I; Brockmoller J
J Clin Oncol; 2003 Jun; 21(11):2147-55. PubMed ID: 12775740
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon.
Wolff MC; Leander JD
Pharmacol Biochem Behav; 1995 Nov; 52(3):571-5. PubMed ID: 8545476
[TBL] [Abstract][Full Text] [Related]
31. Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.
Minton NA
Br J Clin Pharmacol; 1994 Jun; 37(6):525-30. PubMed ID: 7917768
[TBL] [Abstract][Full Text] [Related]
32. The anti-emetic activity of GK-128 in Suncus murinus.
Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
[TBL] [Abstract][Full Text] [Related]
33. [New therapeutic possibilities with drugs affecting serotonin receptors].
Spigset O
Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
[TBL] [Abstract][Full Text] [Related]
34. Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.
Tyers MB
Br J Cancer Suppl; 1992 Dec; 19():S12-3. PubMed ID: 1467194
[No Abstract] [Full Text] [Related]
35. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
[TBL] [Abstract][Full Text] [Related]
36. [An experimental study of the role of a blockade of serotonin 5-HT3 receptors and dopamine D2 receptors in the mechanism of the occurrence of early radiation vomiting in monkeys].
Martirosov KS; Grigor'ev IuG; Zorin VV; Andrianova IE
Radiats Biol Radioecol; 2000; 40(3):277-80. PubMed ID: 10907404
[TBL] [Abstract][Full Text] [Related]
37. New antiemetic drugs.
Sanger GJ
Can J Physiol Pharmacol; 1990 Feb; 68(2):314-24. PubMed ID: 2178755
[TBL] [Abstract][Full Text] [Related]
38. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
Costall B; Domeney AM; Naylor RJ; Tattersall FD
Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
[TBL] [Abstract][Full Text] [Related]
39. The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
Preziosi P; D'Amato M; Del Carmine R; Martire M; Pozzoli G; Navarra P
Eur J Pharmacol; 1992 Oct; 221(2-3):343-50. PubMed ID: 1426010
[TBL] [Abstract][Full Text] [Related]
40. Involvement of a peripheral mechanism in the emesis induced by cardiac glycosides in Suncus murinus.
Kakimoto S; Saito H; Matsuki N
Biol Pharm Bull; 1997 May; 20(5):486-9. PubMed ID: 9178926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
